Compare ANAB & CNXN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ANAB | CNXN |
|---|---|---|
| Founded | 2005 | 1982 |
| Country | | |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Catalog/Specialty Distribution |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.3B | 1.5B |
| IPO Year | N/A | N/A |
| Metric | ANAB | CNXN |
|---|---|---|
| Price | $55.14 | $62.75 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 10 | 0 |
| Target Price | ★ $62.20 | N/A |
| AVG Volume (30 Days) | ★ 436.9K | 104.7K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | ★ 1.28% |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $135.51 | $7.32 |
| Revenue Next Year | N/A | $3.34 |
| P/E Ratio | ★ N/A | $19.07 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $13.99 | $54.97 |
| 52 Week High | $57.65 | $71.17 |
| Indicator | ANAB | CNXN |
|---|---|---|
| Relative Strength Index (RSI) | 63.88 | 52.08 |
| Support Level | $46.85 | $63.35 |
| Resistance Level | $57.65 | $68.88 |
| Average True Range (ATR) | 3.51 | 2.33 |
| MACD | 0.48 | 0.02 |
| Stochastic Oscillator | 81.16 | 40.56 |
AnaptysBio Inc is a clinical-stage biotechnology company. The company is focused on developing antibody product candidates for unmet medical needs in inflammation and immuno-oncology. The company is developing immune cell modulating antibodies, including two wholly owned checkpoint agonists in clinical-stage development, for autoimmune and inflammatory diseases; rosnilimab, PD-1 agonist in a Phase 2b trial for the treatment of moderate-to-severe rheumatoid arthritis (RA) and a Phase 2 trial for the treatment of moderate-to-severe ulcerative colitis (UC); and ANB032, BTLA agonist, in a Phase 2b trial for the treatment of moderate-to-severe atopic dermatitis (AD).
PC Connection Inc is a provider of information technology solutions. It provides products such as computer systems, software and peripheral equipment, networking communications, and other products and accessories that company purchase from manufacturers and distributors. The company also offers services involving design, configuration, and implementation of IT solutions. It conducts business operations through three business segments namely Connection Business Solutions, Connection Enterprise Solutions, and Connection Public Sector Solutions. The company generates maximum revenue Connection Enterprise Solutions segment.